Considerations Concerning Disease Redefinition

被引：3
作者：
Yang, Zu-Yao [1 ]
Fan, Hong [2 ]
Tang, Jin-Ling [1 ]
机构：
[1] Chinese Univ Hong Kong, JC Sch Publ Hlth Primary Care, Div Epidemiol, Fac Med, Hong Kong, Hong Kong, Peoples R China
[2] Nanjing Med Univ, Sch Publ Hlth, Dept Social Med & Hlth Educ, Nanjing, Jiangsu, Peoples R China
来源：
JAMA INTERNAL MEDICINE | 2017年 / 177卷 / 12期
关键词：
D O I：
10.1001/jamainternmed.2017.6139
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1872 / 1873
页数：2
相关论文
共 5 条
  • [1] Guidance for Modifying the Definition of Diseases A Checklist
    Doust, Jenny
    Vandvik, Per O.
    Qaseem, Amir
    Mustafa, Reem A.
    Horvath, Andrea R.
    Frances, Allen
    Al-Ansary, Lubna
    Bossuyt, Patrick
    Ward, Robyn L.
    Kopp, Ina
    Gollogly, Laragh
    Schunemann, Holger
    Glasziou, Paul
    [J]. JAMA INTERNAL MEDICINE, 2017, 177 (07) : 1020 - 1025
  • [2] Hu X F, 2017, Zhonghua Yu Fang Yi Xue Za Zhi, V51, P369, DOI 10.3760/cma.j.issn.0253-9624.2017.05.001
  • [3] Drugs for preventing cardiovascular disease in China - Risk factor thresholds should vary according to resources
    Tang, JL
    Hu, YH
    [J]. BRITISH MEDICAL JOURNAL, 2005, 330 (7492): : 610 - 611
  • [4] Tang JL, 2016, ESSENTIALS EVIDENCE
  • [5] World Health Organization (WHO), 2007, Prevention of Cardiovascular Disease: Guidelines for Assessment and Management of Total Cardiovascular Risk
1